Archive | Redefining Every Stage Investments (RESI) RSS feed for this section

Audience Access Pass – A Runway for Your Fundraising Journey

9 Mar

By Antoinette Lowre, Manager of Business Development, LSN

If you have checked out our lineup of content scheduled for next week but find yourself not ready to start your fundraising round and meet with investors and strategic partnering, consider the Audience Access registration option ($295).

The Audience Access pass allows you to take advantage of LSN’s Global Partnering Campaign and Roadshow Preparation courses, which is built into the agenda for Digital RESI March 14-16. You will also get access to watch all the live investor panels, and entrepreneur workshops, and attend the Innovator’s Pitch Challenge sessions to watch startup CEOs pitch.

The LSN Global Partnering Campaign and Roadshow Preparation course will include 6 classes, 2 per day over the 3 day conference. These courses are focused on where to start with planning and executing a global fundraising campaign and how LSN can help with our vast network of investors.

AAP_March

Another registration option is the RESI Bundle Package. A way to increase your fundraising opportunities and save $1000 to attend both Digital RESI March & RESI June 5-7 in Boston this summer. Check out the RESI Bundle Package options below!

One Ticket for 2 Conferences! 
More investor meetings and more savings with special RESI BUNDLES 
Digital RESI March 14-16
RESIConference.com
RESI June 5-7
The Westin Copley Place, Boston (June 5)
Virtual Partnering only (June 6-7)
Standard Bundle (March 14-16 & June 5-7) Digital Bundle (March 14-16 & June 6-7)
STARTUP $2,190 $3,190 $1,690 $2,690
SERVICE PROVIDER $2,990 $3,990 $2,290 $2,290
TECH HUB (Including Startup Who’ve Raised Less than $2MM USD ) $1,990 $2,390 $1,390 $2,390
Contact us to discuss further

RESI-Boston-2023-June-1100px-border
RESI-Boston-2023-June-1100px

Innovator’s Pitch Challenge Judges at Digital RESI March 

9 Mar

By Karen Deyo, Director of Investor Research, Israel BD, LSN

The Innovator’s Pitch Challenge (IPC) has become one of the highlights of RESI, where entrepreneurs get a chance to pitch their companies to investors and industry experts, as well as RESI attendees in the audience. Digital RESI March will feature over 34 presenting companies across 9 sessions. Early-stage founders and CEOs will have 4-minutes to pitch and 8-9 minutes to engage in Q&A with the judge’s panel. LSN’s network of investors and strategic partners have actively participated in these sessions from the start and make both the IPC and RESI possible by their willingness to take part and give feedback. Below are the judges taking part in the IPC Q&A panels – thank you all for your participation!

Featured Digital RESI March IPC Judges

Ehi Akhirome
Norwest Venture Partners

Navid Alipour
Analytics Ventures

David Apfel
Johnson & Johnson Innovation

Priya Balachandran
Life Science Angels

Carl Barrett
AstraZeneca

Jay Batchu
Xontogeny

Yael Benvenisti
Mediterranean Tower Ventures

Oded Biran
Individual Angel

Elsa Boukadoum
Biogen

Bettina Ernst
BERNINA BioInvest

David Fogel
Mass Medical Angels

Gita Gupta
NextStep Ventures

Tai Harada
Fast Track Initiative

Z Haroon
Julz Co

Ozan Isinak
Keiretsu Forum

Julia Kaufman
Boehringer Ingelheim Venture Fund

John Kim
Aphelion Capital

Merika Koday
Accelerator Life Science Partners

Will Krawczyk
Banner Venture Group

Cheryl Kuai
Sixty Degree Capital

Carla Lema Tome
Spark Therapeutics

Linda Li
Cleveland Clinic Ventures

Kevin Lin
Transcenta Holding

Fiona Mack
Bayer

Alexander Martynov
Biovision Ventures

Milind Parate
Northwell Ventures

Laura Pedroza
High-Tech GrÜnderfonds

Stefan Pflanz
Boehringer Ingelheim Venture Fund

Armin Rump
Otsuka Pharmaceutical

Diana Saraceni
Panakes Partners

Goslik Schepers
Brandon Capital Partners

Shirin Schneeberger
Apollo Health Ventures

Randy Scott
HealthQuest Capital

Steve Seuntjens
Personal Health Solutions

Jill Sorensen
Medical Technology Enterprise Consortium (MTEC)

Karen Spilizewski
RiverVest Venture Partners

Santosh Vetticaden
NuFund Venture Group

Jingjing Wang
Lightstone Ventures

Aaron Welch
SymBiosis Capital Management

RESI-Boston-2023-June-1100px-border

With 500+ Attendees, 34 Entrepreneurs Were Selected to Pitch in the Innovator’s Pitch Challenge

2 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claire

Life Science Nation is excited to announce the list of finalist companies who will be participating in the Innovator’s Pitch Challenge (IPC) at our next conference, Digital RESI, March 14-16!

Over 30 companies representing therapeutics, medical devices, diagnostics, digital health, and R&D / life science tools will be delivering a short pitch followed by a Q&A session with a panel of investors and industry experts. In addition, the companies will have a dedicated landing page, including non-confidential materials of their company, that will be showcased to all RESI attendees as a way for participating companies to boost their exposure.

Below are the participating companies – if you will be attending RESI, please make sure to look out for these companies and be sure to review their pages which will be launched next week!

If you are interested in the upcoming event but are not yet registered, you can register here to join hundreds of early-stage life science companies and investors.

   

RESI-Boston-2023-June-1100px-border

Why Early Entrepreneurs Should Be at Digital RESI In March

2 Mar

By Erika Wu, Business Development Manager, Global Tech Hubs, LSN

A perk about an entirely virtual RESI conference is that any tech hub and early-stage startup from around the world can participate. In the case they miss any live sessions, such as investor-led panels, educational workshops, and the Innovator’s Pitch Challenge, they will be recorded and sent out to all registered attendees. Digital RESI takes place March 14-16, and all attendees who purchase a partnering ticket can reach out and book 1-1 meetings with investors and strategic partners.

If you’re not ready to partner with investors, or it’s your first time at a RESI conference, Life Science Nation (LSN) is offering a special “Seeing is Believing” Audience Access Pass program for only $295. This program is a first of its kind partnership between LSN and the tech hubs and includes a new Entrepreneurial Education Track. This pass is designed for startups who are not quite ready to pay for and attend partnering events but need to get a good idea about how to cater their materials for investors and how to partner effectively.

The tech hub network is always growing, which comprises of incubators, accelerators, non-profits, universities, and government organizations. Tech hubs are a crucial part of the LSN and RESI community as they provide capital, business development and technical support, lab space, and economic development for their cohort of aspiring scientist-entrepreneur and fundraising executives. With this immense support from tech hubs, their group of startups, who’ve raised less than $2M USD in capital, can accelerate their entrepreneurship journey by participating in RESI at a discounted rate.

Reach out to Erika Wu if you are eligible for tech hub rates.

Check out the current tech hubs attending Digital RESI in March:

RESI-Boston-2023-June-1100px-border

Put Your Best Foot Forward and Check Out the RESI Survival Guide

2 Mar

By Antoinette Lowre, Manager of Business Development, LSN

Partnering conferences are an important part of an early-stage company’s journey to raising capital and achieving your fundraising goals. Life Science Nation (LSN) hosts the RESI conference series to provide partnering opportunities with investors and strategic partners. Additionally, LSN provides support to Founders and CEOs to get prepared for meetings by putting their best foot forward and prepping them with the tools necessary to get there. A key tool for making the most of our next conference, Digital RESI, March 14-16 is the RESI Survival Guide.

The RESI Survival Guide covers the 5 major steps to finding success at RESI:

  1. Build a Comprehensive Partnering Profile
  2. Develop your Executive Summary
  3. Refine your Pitch Deck
  4. Craft your Meeting Request Message
  5. Outline a Follow-up Strategy

Read detailed explanations of each step along with examples of executive summaries and meeting requests in the RESI Survival Guide.

Partnering for Digital RESI March is live, and the first round of smart partnering will take place tomorrow, March 3. Make sure to set your schedules up and make time slots available and accept and send meeting requests to secure some meetings on your calendar.

If you did not get a chance to attend one of the Partnering Tutorials, you can review a recording here. The Partnering Tutorial is a terrific way to figure out how to navigate our new partnering system and some tips and tricks on outreach strategy to secure good investor and strategic partner meetings.

If you have any questions about getting into shape for Digital RESI March, or wish to have a consultation on your marketing materials reach out to RESI@lifesciencenation.com and the correct Business Development representative will schedule some time with you to review. Happy Partnering!

RESI-Boston-2023-June-1100px-border

The Art of Raising Money for a Life Sciences Company

23 Feb

By Yang (Kenny) Zhou, Vice President of Marketing, LSN

Kenny-Headshot

Some of the biggest challenges executives of early-stage life sciences companies face is securing financing and forging their first licensing deals. Though they may possess deep scientific knowledge, finding the right investors and partners, and telling their story in a compelling way may require skills they have not yet developed. Life Science Nation works with entrepreneurs to tell their stories, identify potential investors and partners, and connect with them. Daniel Levine  of Levine Media Group interviews Dennis Ford, founder and CEO of Life Science Nation, for BigBio Communications about the journey and challenges life sciences entrepreneurs make when they set out to raise money, what investors care about, and what steps they can take to best ensure their success. Listen here:

Life Science Nation & Brisbane Economic Development Agency (BEDA) Equals RESI Success

23 Feb
Miriam-Kent
Miriam Kent
Interview with Miriam Kent, General Manager, Business Growth, Trade and Talent, Brisbane Economic Development Agency (BEDA)

By Caitlin Dolegowski, Marketing Manager, LSN

Caiti
Caitlin Dolegowski

Life Science Nation (LSN) worked with the Brisbane Economic Development Agency and their MedTech Accelerator cohort in a hybrid Entrepreneurial Education program that culminated at RESI JPM San Francisco. We talked with Miriam Kent, General Manager, Business Growth, Trade and Talent at BEDA to learn more about their take-aways from the education course and RESI conference and hear what is next for the MedTech innovation coming from Brisbane.

Caitlin Dolegowski (CD): Introduce us to Brisbane Economic Development Agency (BEDA) and discuss your focus in the life science industry and how the MedTech Accelerator cohort came to be? 

Miriam Kent: General Manager, Business Growth, Trade and Talent at Brisbane Economic Development Agency: As Brisbane’s champion, BEDA works to enhance and promote the city’s reputation globally, drive visitation, and attract investment and talent in key growth industries.

We support domestic and international investors with full market entry and expansion strategies, while supporting local businesses to scale globally and grow through our accelerator programs.

BEDA’s MedTech Initiative is designed to elevate our exceptional local talent, to attract international investment, and fast-track life-saving medical products to the market.

Brisbane has a strong track-record for innovation thanks to our world-class research institutes and universities. We’re supporting the next generation of companies to stand out in a globally competitive market, to foster fresh developments and discoveries.

CD: BEDA brought a MedTech Accelerator cohort to work with Life Science Nation (LSN) in a hybrid (virtual and in person) educational program and wrapping the program at RESI JPM San Francisco, can you tell us about the startups that attended? 

MK: A rapid test for sepsis, a bionic voice box, and an inhaler for anaphylaxis are just some of the life-changing healthcare innovations produced by the Brisbane cohort.  We were extremely proud to see two Brisbane companies take out gold and bronze in the Innovator’s Pitch Challenge.

Field Orthopaedics impressed the panel of seasoned investors and industry experts to secure the top prize for their innovative surgical screws and nails for treating complex fractures.

Meanwhile, Max Kelsen, claimed bronze with its machine learning solutions that are transforming the way scientists store, analyse and work with data to fast-track vital research.

Leading Brisbane MedTech companies – Clinials, De Motu Cordis, Laronix, Microbio and Midnight Health were also awarded finalist seats and were successful in attracting global investor and partner interest.

CD: Congrats to the BEDA cohort who did very well in the Innovator’s Pitch Challenge at RESI JPM San Francisco, taking 1st and 3rd place! What aspects of the LSN educational program were most useful to help get the companies ready for JPM Week and pitching at RESI? 

MK: While these businesses are experts in their fields, knowing how to pitch their idea and who to pitch to on a global stage can be a challenge for some early-stage ventures looking to secure investment. With the support of Life Science Nation, our cohort members have been able to create strategies and connections to advance their global fundraising campaigns in a pivotal international market.

Throughout the program, the cohort has also benefited from mentorship from peak bodies like Life Sciences QLD, industry leaders like Vaxxas and ASX-listed Microba, as well as advice from local investors and venture capital groups.

CD: The educational program also featured executives from leading MedTech firms such as Stryker and Philips; how do you think their contributions shaped the success of the cohort at RESI JPM? 

MK: Insights shared by global leaders like Stryker provide invaluable context and underline the importance of a refined and strategic funding campaign.

Stryker’s recent investment in Brisbane’s Herston Quarter health precinct will help drive medical technology, innovation, and collaboration to improve patient outcomes and solidify our city’s capability and reputation as a global science and research leader.

CD: Did the mix of virtual content over several months and in-person tutoring at the start of the JPM Week work well? 

MK: The mix of virtual and in-person content ensures we can deliver an intensive, comprehensive learning experience, in a convenient way for leaders with busy schedules.

It is exciting to see the discussion and collaborations across continents.

CD: What is next for BEDA’s MedTech Accelerator cohort? 

MK: The feedback we’ve received has been hugely positive and we look forward to working with a new cohort for year two of our MedTech Accelerator in 2023.

The outstanding success of our local start-ups, in a competitive global market, is a testament to the quality of the research and development that’s happening here in Brisbane.

We’d like to thank Life Science Nation for partnering with us to support this vital industry.
MicrosoftTeams-image (5)